MEPRON (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the MEPRON drug offered from GlaxoSmithKline LLC. This Antimalarial [EPC],Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | atovaquone |
| SUBSTANCE NAME: | ATOVAQUONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimalarial [EPC],Antiprotozoal [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-09-18 |
| END MARKETING DATE: | 0000-00-00 |
MEPRON HUMAN PRESCRIPTION DRUG Details:
| Item Description | MEPRON from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 750(mg/5mL) |
| START MARKETING DATE: | 1998-09-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0547_97061221-24f2-435b-8dc9-dd6862dddc81 |
| PRODUCT NDC: | 0173-0547 |
| APPLICATION NUMBER: | NDA020500 |
Other ATOVAQUONE Pharmaceutical Manufacturers / Labelers:
